Back
EHRA 2024 Premium Access

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial

Session: Atrial fibrillation: treatment 1
Topic: Oral Anticoagulation
Speaker: Doctor S. van Doorn (Utrecht, NL)
Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Sander van Doorn

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

7 more presentations in this session

Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application

Speaker: Doctor H. Gruwez (Genk, BE)

Access
Abstract
Slides
Video
Thumbnail

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

Speaker: Doctor A. Rillig (Hamburg, DE)

Access
Abstract
Slides
Video
Thumbnail

Management of edoxaban therapy in patients undergoing emergency/urgent procedures: a subanalysis of the global, prospective, observational, multinational EMIT-AF/VTE programme

Speaker: Professor C. Von Heymann (Berlin, DE)

Access
Abstract
Slides
Video
Thumbnail

Impact of different dose reduction criteria on dose assignment of current DOACs and related outcomes: an analysis from 4-year data of the ETNA-AF Europe programme

Speaker: Assistant Professor I. Diemberger (Bologna, IT)

Access
Abstract
Slides
Video
Thumbnail

Difference between cryoballoon and radiofrequency ablations for atrial fibrillation based on electroanatomical mechanisms

Speaker: Doctor M. Kim (Yongin, KR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation: treatment 1

Speakers: Doctor S. van Doorn, Doctor H. Gruwez, Doctor A. Rillig, Professor C. Von Heymann, Assistant Professor I. Diemberger...
Access
Thumbnail

About the event

Image

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb